Note 10 - Accrued Expenses

12 Months Ended

Dec. 31, 2024

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

10. Accrued Expenses

Accrued expenses consist of the following:

	As of December 31,
	2024		2023
Compensation and related expenses	$	6,828	$	7,927
Professional fees		2,485		2,274
Operating lease liability- current		1,918		1,827
Share based compensation		1,213		-
Clinical trial costs		295		460
Income taxes payable		63		1,240
Other		765		338
Total	$	13,567	$	14,066